End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,040 EUR | 0.00% | -0.97% | +13.33% |
Feb. 28 | SALUS, Ljubljana, d. d. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 09 | SALUS, Ljubljana, d. d. cancelled the acquisition of Farmadent S.R.L. | CI |
Sales 2022 | 496M 530M | Sales 2023 | 599M 641M | Capitalization | 190M 203M |
---|---|---|---|---|---|
Net income 2022 | 13M 13.9M | Net income 2023 | 10M 10.69M | EV / Sales 2022 | 0.29 x |
Net cash position 2022 | 3.06M 3.27M | Net cash position 2023 | 586K 626K | EV / Sales 2023 | 0.32 x |
P/E ratio 2022 |
11.1
x | P/E ratio 2023 |
18.4
x | Employees | 582 |
Yield 2022 |
5.04% | Yield 2023 |
3.89% | Free-Float | 72.87% |
1 week | -0.97% | ||
3 months | +16.57% | ||
6 months | +29.11% | ||
Current year | +13.33% |
Managers | Title | Age | Since |
---|---|---|---|
Žiga Hieng
CEO | Chief Executive Officer | 44 | 12-12-31 |
Nina Tomšic
IRO | Public Communications Contact | - | - |
Gregor Jenko
IRC | Investor Relations Contact | 44 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Jencic
BRD | Director/Board Member | 43 | 18-04-26 |
Gregor Jenko
IRC | Investor Relations Contact | 44 | - |
Boris Šefman
CHM | Chairman | 73 | 02-04-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 2,040 | 0.00% | 16 |
24-04-22 | 2,040 | 0.00% | 1 |
24-04-19 | 2,040 | -0.97% | 48 |
End-of-day quote Ljubljana S.E., April 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+13.33% | 230M | |
-14.63% | 8.35B | |
+34.44% | 1.35B | |
+7.12% | 428M | |
+8.08% | 294M | |
-9.17% | 84.32M | |
-45.37% | 84.64M | |
+19.97% | 59.71M |
- Stock Market
- Equities
- SALR Stock